Biotricity Inc
OTC:BTCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biotricity Inc
OTC:BTCY
|
US |
|
Saferoads Holdings Ltd
ASX:SRH
|
AU |
|
Staffline Group PLC
LSE:STAF
|
UK |
|
Graphano Energy Ltd
XTSX:GEL
|
CA |
|
Ab Dynamics PLC
LSE:ABDP
|
UK |
|
V
|
Vercom SA
WSE:VRC
|
PL |
|
Nilorngruppen AB
STO:NIL B
|
SE |
|
Over The Wire Holdings Ltd
ASX:OTW
|
AU |
|
Samudera Indonesia Tbk PT
IDX:SMDR
|
ID |
|
Westbridge Renewable Energy Corp.
OTC:WEGYD
|
CA |
|
R
|
Ryde Group Ltd
AMEX:RYDE
|
SG |
|
ICBC Turkey Bank AS
IST:ICBCT.E
|
TR |
Biotricity Inc
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
